Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Holmes

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|October 5, 2007
Donepezil for the treatment of agitation in Alzheimer's diseaseRobert J Howard, Edmund Juszczak, Clive G Ballard, et al.
Trials|July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocolCaroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2011
A multi-center study of ACE and the risk of late-onset Alzheimer's diseaseOlivia Belbin, Kristelle Brown, Hui Shi, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2012
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trialRenee Romeo, Martin Knapp, Jennifer Hellier, et al.
Lancet (London, England)|July 19, 2011
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialSube Banerjee, Jennifer Hellier, Michael Dewey, et al.
Dementia and Geriatric Cognitive Disorders|November 8, 2007
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part IPauline Aalten, Frans R J Verhey, Marina Boziki, et al.
Dementia and Geriatric Cognitive Disorders|November 21, 2007
Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part IIPauline Aalten, Frans R J Verhey, Marina Boziki, et al.
Journal of Neurochemistry|June 2, 2016
Targeting innate immunity for neurodegenerative disorders of the central nervous systemKatrin I Andreasson, Adam D Bachstetter, Marco Colonna, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|October 5, 2007
Donepezil for the treatment of agitation in Alzheimer's diseaseRobert J Howard, Edmund Juszczak, Clive G Ballard, et al.
Trials|July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocolCaroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2011
A multi-center study of ACE and the risk of late-onset Alzheimer's diseaseOlivia Belbin, Kristelle Brown, Hui Shi, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2012
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trialRenee Romeo, Martin Knapp, Jennifer Hellier, et al.
Lancet (London, England)|July 19, 2011
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialSube Banerjee, Jennifer Hellier, Michael Dewey, et al.
Dementia and Geriatric Cognitive Disorders|November 8, 2007
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part IPauline Aalten, Frans R J Verhey, Marina Boziki, et al.
Dementia and Geriatric Cognitive Disorders|November 21, 2007
Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part IIPauline Aalten, Frans R J Verhey, Marina Boziki, et al.
Journal of Neurochemistry|June 2, 2016
Targeting innate immunity for neurodegenerative disorders of the central nervous systemKatrin I Andreasson, Adam D Bachstetter, Marco Colonna, et al.
Pageof 13